PHR on NYSE

Phreesia Inc.

Logo: SeekVectorLogo.Com, Public domain, via Wikimedia Commons⁴

Healthcare technology company

Phreesia, Inc. is a software as a service company that offers healthcare organizations a set of applications to automate and manage patient intake.³ From Wikipedia, CC BY-SA 4.0

Price unavailable

Last updated Oct 18, 2026.

Overview

$467.8MRevenue, fiscal 2026⁵

$2.3MNet income, fiscal 2026⁵

2005Founded¹

Compare with Uxin Ltd, LIQUIDITY SERVICES INC or RESOURCES CONNECTION, INC., or pick any stock.

TickerPHR on NYSE¹
IndustryServices-Business Services, NEC¹
HeadquartersNew York City¹
Websitewww.phreesia.com
Incorporated inDE⁶
Business address1521 Concord Pike, Suite 301 Pmb 221, Wilmington, De 19803⁶
Filer categoryLarge accelerated filer⁶

See how the biggest companies compare on our leaderboards

Phreesia, Inc. is a software as a service company that offers healthcare organizations a set of applications to automate and manage patient intake.³

Financials

From the company’s reports to the SEC. Every number links to the filing it came from.

Key numbers, fiscal 2026

-1.4%Operating margin⁵

0.5%Net margin⁵

14.0%Revenue growth, 2026⁵

0.7%Return on equity⁵

0.01×Debt to equity⁵

$67.7MFree cash flow⁵

What sells

Revenue by product, business segment and region, as the company reports it to the SEC.

Products and services

Subscription And Services brought in 46% of the revenue Phreesia Inc. broke down this way in fiscal 2026.

Subscription And Services$219.5M⁵46%up 12% from 2025
Network Solutions$139.7M⁵29%up 15% from 2025
Payment Solutions$121.5M⁵25%up 19% from 2025

Products and services by year

Products and services	2024	2025	2026
Subscription And Services	$165.4M	$196.5M	$219.5M
Network Solutions	$96.3M	$121.6M	$139.7M
Payment Solutions	$94.6M	$101.7M	$121.5M

Where the money goes

Where each dollar of revenue went, fiscal 2026

Research and developmentOther costs

Research and development26¢$121.5M
Other costs71¢$332.8M
Income tax2¢$11.2M
Profit0¢$2.3M

Out of $467.8M in revenue.⁵

Where each dollar of operating cash went, fiscal 2026

Capital spendingKept or used elsewhere

Capital spending14¢$11.1M
Kept or used elsewhere86¢$67.7M

Out of $78.8M of cash from operations.⁵

Financial statements

Revenue⁸⁹¹⁰¹¹¹²⁵$467.8M in 2026+368% since 2019

Operating income⁸⁹¹⁰¹¹¹²⁵-$6.6M in 2026−30% since 2019

Net income⁸⁹¹⁰¹¹¹²⁵$2.3M in 2026

Every line of the income statement as filed: the last 3 fiscal years, latest first.⁵

Period ending	2026-01-31	2025-01-31	2024-01-31
Total revenues	$480.6M	$419.8M	$356.3M
Cost of revenue (excluding depreciation and amortization)	$71.4M	$66.2M	$61.0M
Payment solutions expense	$82.8M	$68.7M	$63.0M
Sales and marketing	$100.2M	$121.1M	$147.0M
Research and development	$121.5M	$117.4M	$112.3M
General and administrative	$79.9M	$76.6M	$79.9M
Depreciation	$13.0M	$14.2M	$17.6M
Amortization	$18.5M	$13.7M	$11.9M
Total expenses	$487.2M	$477.9M	$492.8M
Operating loss	-$6.6M	-$58.1M	-$136.5M
Other income, net	$3.0M	$2.0M	$44.0K
Loss on extinguishment of debt	-$501.0K	$0	-$1.1M
Interest expense	-$7.0M	-$2.3M	-$1.9M
Interest income	$2.2M	$2.7M	$4.1M
Total other (expense) income, net	-$2.3M	$2.3M	$1.1M
Loss before income tax expense	-$8.9M	-$55.8M	-$135.3M
Income tax benefit (expense)	$11.2M	-$2.7M	-$1.5M
Net income (loss)	$2.3M	-$58.5M	-$136.9M
Net income (loss) per share attributable to common stockholders - basic (in dollars per share)	$0.04	-$1.02	-$2.51
Net income (loss) per share attributable to common stockholders - diluted (in dollars per share)	$0.04	-$1.02	-$2.51
Weighted-average common shares outstanding - basic (in shares)	59.7M shares	57.6M shares	54.6M shares
Weighted-average common shares outstanding - diluted (in shares)	61.5M shares	57.6M shares	54.6M shares

Total assets¹⁵⁸⁹¹⁰¹¹¹²⁵$663.8M in 2026+1020% since 2019

Total liabilities¹⁵⁸⁹¹⁰¹¹¹²⁵$326.6M in 2026+412% since 2019

Shareholders’ equity⁹¹⁰¹¹¹²⁵$337.2M in 2026

Cash¹⁵⁸⁹¹⁰¹¹¹²⁵$73.8M in 2026+4685% since 2019

Long-term debt¹⁵⁸⁹¹⁰¹¹¹²⁵$2.7M in 2026−90% since 2019

Every line of the balance sheet as filed: the last 5 fiscal years (annual) or 5 quarters (quarterly), latest first.⁵

Period ending	2026-01-31	2025-01-31	2024-01-31	2023-01-31	2019-07-31
Cash, cash equivalents, and restricted cash (including restricted cash of $1,691)	$73.8M	$84.2M
Settlement assets	$33.0M	$29.2M
Accounts receivable, net of allowance for doubtful accounts of $1,523 and $1,468 as of January 31, 2026 and 2025, respectively	$97.5M	$73.6M
Cardholder receivables	$38.3M	$0
Deferred purchase price receivables	$18.0M	$0
Accrued interest and fees receivables	$840.0K	$0
Deferred contract acquisition costs	$410.0K	$401.0K
Prepaid expenses and other current assets	$18.0M	$15.9M
Total current assets	$279.8M	$203.3M
Property and equipment, net of accumulated depreciation and amortization of $94,193 and $84,505 as of January 31, 2026 and 2025, respectively	$20.3M	$23.7M
Capitalized internal-use software, net of accumulated amortization of $69,390 and $55,991 as of January 31, 2026 and 2025, respectively	$54.3M	$52.8M
Operating lease right-of-use assets	$2.0M	$1.5M
Deferred contract acquisition costs	$338.0K	$583.0K
Intangible assets, net of accumulated amortization of $13,489 and $8,407 as of January 31, 2026 and 2025, respectively	$79.8M	$28.1M
Goodwill	$170.1M	$75.8M	$75.8M
Deferred tax assets	$1.6M	$0
Other assets	$2.4M	$2.7M
Long-term cardholder receivables	$47.7M	$0
Long-term deferred purchase price receivables	$5.4M	$0
Total Assets	$663.8M	$388.4M
Settlement obligations	$33.0M	$29.2M
Current portion of debt and finance lease liabilities	$8.0M	$8.0M
Current portion of operating lease liabilities	$1.3M	$964.0K
Accounts payable	$11.5M	$5.6M
Accrued expenses	$41.3M	$37.5M
Due to healthcare providers	$38.1M	$0
Deferred revenue	$49.5M	$32.8M
Other current liabilities	$705.0K	$0
Total current liabilities	$183.2M	$114.0M
Long-term debt and finance lease liabilities	$92.1M	$8.2M
Operating lease liabilities, non-current	$1.1M	$646.0K
Long-term due to healthcare providers	$45.3M	$0
Long-term deferred revenue	$244.0K	$119.0K
Long-term deferred tax liabilities	$4.5M	$484.0K
Other long-term liabilities	$47.0K	$185.0K
Total Liabilities	$326.6M	$123.6M
Preferred stock, undesignated, $0.01 par value$20,000,000 shares authorized as of both January 31, 2026 and 2025; no shares issued or outstanding as of January 31, 2026 and 2025, respectively	$0	$0
Common stock, $0.01 par value500,000,000 shares authorized as of both January 31, 2026 and 2025; 62,020,186 and 60,083,444 shares issued as of January 31, 2026 and 2025, respectively	$620.0K	$601.0K
Additional paid-in capital	$1.2B	$1.1B
Accumulated deficit	-$799.2M	-$801.5M
Accumulated other comprehensive loss	-$382.0K	-$51.0K
Treasury stock, at cost, 1,355,169 shares as of both January 31, 2026 and 2025	-$45.5M	-$45.5M
Total Stockholders Equity	$337.2M	$264.8M	$251.4M	$287.8M
Total Liabilities and Stockholders Equity	$663.8M	$388.4M
Accounts receivable, allowance for doubtful accounts	$1.5M	$1.5M	$1.4M
Accumulated depreciation and amortization, net	$94.2M	$84.5M
Accumulated amortization of capitalized internal-use software	$69.4M	$56.0M
Accumulated amortization of intangible assets	$13.5M	$8.4M
Preferred stock par value (in dollars per share)	$0.01	$0.01
Preferred stock authorized (in shares)	20.0M shares	20.0M shares
Preferred stock issued (in shares)	0 shares	0 shares
Preferred stock outstanding (in shares)	0 shares	0 shares
Common stock, par value (in dollars per share)	$0.01	$0.01			$0.01
Common stock, shares authorized (in shares)	500.0M shares	500.0M shares			500.0M shares
Common stock, shares issued (in shares)	62.0M shares	60.1M shares
Treasury stock (in shares)	1.4M shares	1.4M shares

Period ending	2026-01-31	2025-01-31	2024-01-31	2023-01-31	2019-07-31
Cash, cash equivalents, and restricted cash (including restricted cash of $1,691)	$73.8M	$84.2M
Settlement assets	$33.0M	$29.2M
Accounts receivable, net of allowance for doubtful accounts of $1,523 and $1,468 as of January 31, 2026 and 2025, respectively	$97.5M	$73.6M
Cardholder receivables	$38.3M	$0
Deferred purchase price receivables	$18.0M	$0
Accrued interest and fees receivables	$840.0K	$0
Deferred contract acquisition costs	$410.0K	$401.0K
Prepaid expenses and other current assets	$18.0M	$15.9M
Total current assets	$279.8M	$203.3M
Property and equipment, net of accumulated depreciation and amortization of $94,193 and $84,505 as of January 31, 2026 and 2025, respectively	$20.3M	$23.7M
Capitalized internal-use software, net of accumulated amortization of $69,390 and $55,991 as of January 31, 2026 and 2025, respectively	$54.3M	$52.8M
Operating lease right-of-use assets	$2.0M	$1.5M
Deferred contract acquisition costs	$338.0K	$583.0K
Intangible assets, net of accumulated amortization of $13,489 and $8,407 as of January 31, 2026 and 2025, respectively	$79.8M	$28.1M
Goodwill	$170.1M	$75.8M	$75.8M
Deferred tax assets	$1.6M	$0
Other assets	$2.4M	$2.7M
Long-term cardholder receivables	$47.7M	$0
Long-term deferred purchase price receivables	$5.4M	$0
Total Assets	$663.8M	$388.4M
Settlement obligations	$33.0M	$29.2M
Current portion of debt and finance lease liabilities	$8.0M	$8.0M
Current portion of operating lease liabilities	$1.3M	$964.0K
Accounts payable	$11.5M	$5.6M
Accrued expenses	$41.3M	$37.5M
Due to healthcare providers	$38.1M	$0
Deferred revenue	$49.5M	$32.8M
Other current liabilities	$705.0K	$0
Total current liabilities	$183.2M	$114.0M
Long-term debt and finance lease liabilities	$92.1M	$8.2M
Operating lease liabilities, non-current	$1.1M	$646.0K
Long-term due to healthcare providers	$45.3M	$0
Long-term deferred revenue	$244.0K	$119.0K
Long-term deferred tax liabilities	$4.5M	$484.0K
Other long-term liabilities	$47.0K	$185.0K
Total Liabilities	$326.6M	$123.6M
Preferred stock, undesignated, $0.01 par value$20,000,000 shares authorized as of both January 31, 2026 and 2025; no shares issued or outstanding as of January 31, 2026 and 2025, respectively	$0	$0
Common stock, $0.01 par value500,000,000 shares authorized as of both January 31, 2026 and 2025; 62,020,186 and 60,083,444 shares issued as of January 31, 2026 and 2025, respectively	$620.0K	$601.0K
Additional paid-in capital	$1.2B	$1.1B
Accumulated deficit	-$799.2M	-$801.5M
Accumulated other comprehensive loss	-$382.0K	-$51.0K
Treasury stock, at cost, 1,355,169 shares as of both January 31, 2026 and 2025	-$45.5M	-$45.5M
Total Stockholders Equity	$337.2M	$264.8M	$251.4M	$287.8M
Total Liabilities and Stockholders Equity	$663.8M	$388.4M
Accounts receivable, allowance for doubtful accounts	$1.5M	$1.5M	$1.4M
Accumulated depreciation and amortization, net	$94.2M	$84.5M
Accumulated amortization of capitalized internal-use software	$69.4M	$56.0M
Accumulated amortization of intangible assets	$13.5M	$8.4M
Preferred stock par value (in dollars per share)	$0.01	$0.01
Preferred stock authorized (in shares)	20.0M shares	20.0M shares
Preferred stock issued (in shares)	0 shares	0 shares
Preferred stock outstanding (in shares)	0 shares	0 shares
Common stock, par value (in dollars per share)	$0.01	$0.01			$0.01
Common stock, shares authorized (in shares)	500.0M shares	500.0M shares			500.0M shares
Common stock, shares issued (in shares)	62.0M shares	60.1M shares
Treasury stock (in shares)	1.4M shares	1.4M shares

Cash from operations⁸⁹¹⁰¹¹¹²⁵$78.8M in 2026

Capital spending⁸⁹¹⁰¹¹¹²⁵$11.1M in 2026+135% since 2019

Free cash flow⁸⁹¹⁰¹¹¹²⁵$67.7M in 2026

Every line of the cash flow as filed: the last 3 fiscal years, latest first.⁵

Period ending	2026-01-31	2025-01-31	2024-01-31
Net income (loss)	$2.3M	-$58.5M	-$136.9M
Depreciation and amortization	$31.5M	$27.9M	$29.5M
Stock-based compensation expense	$67.5M	$67.0M	$71.6M
Amortization of deferred financing costs and debt discount	$3.0M	$236.0K	$321.0K
Loss on extinguishment of debt	$501.0K	$0	$1.1M
Non-cash gain on settlement	$0	-$2.3M	$0
Cost of Phreesia hardware purchased by customers	$1.0M	$1.9M	$1.6M
Deferred contract acquisition costs amortization	$570.0K	$1.8M	$1.1M
Non-cash operating lease expense	$914.0K	$747.0K	$702.0K
Deferred taxes	-$13.3M	$214.0K	$228.0K
Gains and losses for fair value option	-$1.0M	$0	$0
Accounts receivable	-$23.4M	-$8.8M	-$11.2M
Collections of principal on receivables originally held for sale to securitization	$13.7M	$0	$0
Accrued Interest Receivable	-$446.0K	$0	$0
Prepaid expenses and other assets	-$1.4M	-$1.4M	-$2.2M
Deferred contract acquisition costs	-$334.0K	-$1.0M	$0
Accounts payable	$5.3M	-$3.2M	-$2.0M
Accrued expenses and other liabilities	$2.9M	$182.0K	$14.2M
Payment of due to provider for receivables originally held for sale to securitization	-$17.6M	$0	$0
Lease liabilities	-$1.1M	-$824.0K	-$1.2M
Deferred revenue	$8.3M	$8.7M	$731.0K
Net cash provided by (used in) operating activities	$78.8M	$32.4M	-$32.4M
Collections of cardholder receivables held for investment and deferred purchase price	$15.7M	$0	$0
Acquisitions, net of cash acquired	-$153.2M	$0	-$14.6M
Capitalized internal-use software	-$13.3M	-$15.4M	-$19.3M
Purchases of property and equipment	-$11.1M	-$8.7M	-$5.8M
Net cash used in investing activities	-$161.9M	-$24.1M	-$39.7M
Proceeds from issuance of common stock upon exercise of stock options	$1.5M	$1.0M	$955.0K
Treasury stock to satisfy tax withholdings on stock compensation awards	$0	$0	-$12.2M
Proceeds from employee stock purchase plan	$2.4M	$2.9M	$3.2M
Finance lease payments	-$6.8M	-$7.8M	-$6.8M
Constructive financing	$0	$0	$1.7M
Principal payments on financing agreements	-$1.3M	-$1.2M	-$600.0K
Debt issuance costs and loan facility fee payments	-$3.2M	-$152.0K	-$1.3M
Financing payments of acquisition-related liabilities	$0	-$6.3M	-$1.3M
Debt extinguishment costs	$0	$0	-$758.0K
Proceeds from debt instruments	$110.0M	$0	$0
Principal payments on debt instruments	-$20.0M	$0	$0
Payments due to provider for unfunded receivables	-$9.6M	$0	$0
Net cash provided by (used in) financing activities	$72.9M	-$11.5M	-$17.1M
Effect of exchange rate changes on cash, cash equivalents and restricted cash	-$176.0K	-$106.0K	$0
Net decrease in cash, cash equivalents and restricted cash	-$10.4M	-$3.3M	-$89.2M
Non-cash activity related to credit card receivables and deferred purchase price	$17.6M	$0	$0
Right of use assets acquired in exchange for operating lease liabilities	$0	$2.0M	$398.0K
Property and equipment acquisitions through finance leases	$0	$13.7M	$7.4M
Purchase of property and equipment and capitalized software included in accounts payable and accrued liabilities	$2.0M	$1.8M	$1.3M
Capitalized stock-based compensation	$1.3M	$1.4M	$1.4M
Issuance of stock to settle liabilities for stock-based compensation	$12.7M	$11.9M	$12.3M
Deferred consideration liabilities payable in business combinations	$0	$0	$8.7M
Issuance of stock as consideration in business combinations	$0	$0	$35.3M
Capitalized software acquired through vendor financing	$0	$0	$2.0M
Interest	$1.6M	$2.2M	$1.3M
Income taxes	$1.9M	$3.1M	$37.0K

Compare Phreesia Inc. with another company

The story

Headquartered in Wilmington, Delaware, Phreesia employs approximately 1400 people across the United States and Canada. Phreesia was founded in January 2005 by CEO Chaim Indig and COO Evan Roberts. Michael Weintraub has remained chairman of the company's board since its founding. Phreesia develops patient intake and "digital engagement" solutions.

On July 18, 2019, Phreesia (PHR) completed its initial public offering and is listed on the New York Stock Exchange (NYSE).

In 2021, Phreesia acquired schedule-management solution QueueDr, now offered to Phreesia clients as Appointment Accelerator. In December 2021, it also announced the acquisition of Insignia Health, licensor of the Patient Activation Measure. In August 2023, it was announced that Phreesia had acquired the Sulphur Springs-headquartered electronic forms management and automation provider Access eForms for an undisclosed amount.

From Wikipedia’s article on Phreesia, shared under CC BY-SA 4.0.⁷

Leadership

Who has led Phreesia Inc., and when. Pick a name to see everywhere that person has worked.

Chief executive

Chaim Indig2019–now

President

Chief financial officer

Chief operating officer

Evan Roberts2019–now

2010201520202025

Chief executive officerChaim Indig Jul 17, 2019 to now¹⁶
PresidentDavid Linetsky Aug 20, 2025 to Aug 29, 2025¹⁷
PresidentEvan Roberts Aug 29, 2025 to now¹⁸
Chief financial officerBalaji Gandhi Mar 28, 2023 to now¹⁹
Chief financial officerRandy Rasmussen May 5, 2021 to Feb 6, 2023²⁰
Chief financial officerThomas Altier Jul 17, 2019 to Feb 19, 2021²¹
Chief operating officerEvan Roberts Jul 17, 2019 to now²²

Board members and other officers (17)

Principal Accounting OfficerYvonne Hui Jun 27, 2024 to now²³
Principal Accounting OfficerJanet Gunzburg Mar 28, 2023 to Jun 24, 2024²⁴
SVP, Human ResourcesAmy Beth Vanduyn Jul 17, 2019 to now²⁵
Chief Technology OfficerDaniel Nathan Jul 17, 2019 to Aug 4, 2020²⁶
SVP, Life SciencesDavid Linetsky Jul 17, 2019 to now²⁷
OfficerMichael J. Davidoff Jul 17, 2019 to Jan 18, 2024²⁸
Board memberLisa Egbuonu-Davis Jul 13, 2023 to now²⁹
Board memberRamin Sayar Oct 1, 2021 to now³⁰
Board memberLainie Goldstein Jul 22, 2020 to now³¹
Board memberChaim Indig Jul 17, 2019 to now¹⁶
Board memberCheryl Pegus Jul 17, 2019 to Feb 23, 2022³²
Board memberEdward L. Cahill Jul 17, 2019 to now³³
Board memberGillian Munson Jul 17, 2019 to now³⁴
Board memberMichael Weintraub Jul 17, 2019 to now³⁵
Board memberScott Perricelli Jul 17, 2019 to Feb 16, 2021³⁶
General counselAllison C. Hoffman Aug 26, 2020 to now³⁷
General counselCharles Kallenbach Jul 17, 2019 to Aug 20, 2020³⁸

Former names

Phreesia IncSep 11, 2007 to Feb 23, 2009⁶

Timeline

Jul 17, 2019New chief executive Chaim Indig becomes CEO¹⁶
2005Founded Founded¹

Filings

966 filings to the SEC since October 2021: 5 annual reports, 15 quarterly reports, 39 major events, 565 insider forms, 42 large holders, 300 other. The latest 20:

The 966 filings since October 2021 can be filtered by form type and year here when JavaScript is on.

Every filing from the last three years, summarized. The full record is on SEC EDGAR.

Insider trades and holders

Large holders

Investors who own more than 5% must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively. 42 such filings since October 2021, the latest 10:

From Forms 4 and Schedules 13D and 13G filed with the SEC.

Held by these funds

The largest holders among investment managers' 13F reports for the quarter ending Jun 30, 2026, the top 25 of 100. Change is in shares since the quarter before.

Fund	Shares	Value	Share of the fund	Change
Pale Fire Capital SE	8,924,329	$91.8M	6.5%	+275,000
BlackRock, Inc.	7,019,832	$72.2M	0.0%	+1,099,363
Aqr Capital Management LLC	3,151,453	$32.4M	0.0%	+1,298,894
Vanguard Portfolio Management LLC	2,987,907	$30.7M	0.0%	−347,214
Vanguard Capital Management LLC	2,548,965	$26.2M	0.0%	+69,718
State Street Corp	1,577,463	$16.2M	0.0%	+103,517
Goldman Sachs Group Inc	1,435,314	$14.8M	0.0%	+404,499
Geode Capital Management, LLC	1,312,056	$13.5M	0.0%	−59,738
Algert Global LLC	1,205,481	$12.4M	0.1%	−175,393
Jacobs Levy Equity Management, Inc	1,113,782	$11.5M	0.0%	+38,022
Morgan Stanley	1,000,388	$10.3M	0.0%	+270,679
Nordea Investment Management Ab	784,279	$8.0M	0.0%	New
OP Asset Management Ltd	705,874	$7.3M	0.1%	−68,270
Bnp Paribas Financial Markets	698,173	$7.2M	0.0%	−57,557
Rock Springs Capital Management LP	696,900	$7.2M	0.4%	+96,500
Nuveen, LLC	675,234	$6.9M	0.0%	−332,993
Whetstone Capital Advisors, LLC	629,752	$6.5M	1.7%	−324,176
Northern Trust Corp	621,688	$6.4M	0.0%	+108,392
Connor, Clark & Lunn Investment Management Ltd.	609,704	$6.3M	0.0%	+28,295
Bank Of America Corp /de/	589,515	$6.1M	0.0%	−411,542
D. E. Shaw & Co., Inc.	524,496	$5.4M	0.0%	+512,955
Qube Research & Technologies Ltd	517,767	$5.3M	0.0%	+207,396
Point72 Asset Management, L.P.	484,115	$5.0M	0.0%	New
Charles Schwab Investment Management Inc	473,462	$4.9M	0.0%	−9,494
Fmr LLC	463,002	$4.8M	0.0%	+107,319

13F reports cover disclosed long positions in U.S. stocks only.

Members of Congress who traded it

14 trades disclosed by members of Congress. “Vs S&P since” is the stock’s change since the trade minus the S&P 500’s.

Date	Member	Trade	Amount	Vs S&P since	Filing
Aug 26, 2026	Gilbert Ray Cisneros, Jr.Democratic, House	Sale	$1,001 - $15,000	+5.6%	Report
Aug 25, 2026	Gilbert Ray Cisneros, Jr.Democratic, House	Partial sale	$1,001 - $15,000	+4.9%	Report
Mar 5, 2026	Josh GottheimerDemocratic, House	Sale	$1,001 - $15,000	+21.9%	Report
Oct 9, 2025	Gilbert Ray Cisneros, Jr.Democratic, House	Buy	$1,001 - $15,000	−68.7%	Report
Oct 16, 2023	Josh GottheimerDemocratic, House	Buy	$1,001 - $15,000	−109.6%	Report
Sep 15, 2023	Josh GottheimerDemocratic, House	Partial sale	$1,001 - $15,000	+118.8%	Report
Dec 15, 2021	Josh GottheimerDemocratic, House	Buy	$1,001 - $15,000	−137.5%	Report
Dec 23, 2020	Gilbert Ray Cisneros, Jr.Democratic, House	Partial sale	$1,001 - $15,000	+190.9%	Report
Dec 21, 2020	Josh GottheimerDemocratic, House	Partial sale	$1,001 - $15,000	+189.2%	Report
Oct 27, 2020	Gilbert Ray Cisneros, Jr.Democratic, House	Buy	$1,001 - $15,000	−199.9%	Report
Sep 29, 2020	Gilbert Ray Cisneros, Jr.Democratic, House	Buy	$1,001 - $15,000	−196.5%	Report
Apr 23, 2020	Gilbert Ray Cisneros, Jr.Democratic, House	Buy	$1,001 - $15,000	−229.6%	Report
Feb 10, 2020	Gilbert Ray Cisneros, Jr.Democratic, House	Buy	$1,001 - $15,000	−196.9%	Report
Feb 3, 2020	Josh GottheimerDemocratic, House	Buy	$1,001 - $15,000	−203.0%	Report

Members report amounts as ranges, not exact figures. Returns are price-only (no dividends).

Sources

The numbers on this page point here. Each one links to the record it came from.

1
WikidataPhreesia Inc. on Wikidata
2
SEC EDGARPhreesia Inc. filings on SEC EDGAR
3
WikipediaPhreesia Inc. on Wikipedia
4
Wikimedia CommonsPhreesia Inc. logo by SeekVectorLogo.Com, Public domain
5
SEC EDGARPhreesia Inc. 10-K for fiscal 2026
6
SEC EDGARPhreesia Inc. filings on SEC EDGAR
7
WikipediaPhreesia Inc. on Wikipedia (revision used)
8
SEC EDGARPhreesia Inc. 10-K for fiscal 2019
9
SEC EDGARPhreesia Inc. 10-K for fiscal 2020
10
SEC EDGARPhreesia Inc. 10-K for fiscal 2021
11
SEC EDGARPhreesia Inc. 10-K for fiscal 2022
12
SEC EDGARPhreesia Inc. 10-K for fiscal 2023
13
SEC EDGARPhreesia Inc. 10-Q for fiscal 2026
14
SEC EDGARPhreesia Inc. 10-Q for fiscal 2026
15
SEC EDGARPhreesia Inc. 10-K for fiscal 2019
16
SEC EDGARChaim Indig, Chief executive officer
17
SEC EDGARDavid Linetsky, President
18
SEC EDGAREvan Roberts, President
19
SEC EDGARBalaji Gandhi, Chief financial officer
20
SEC EDGARRandy Rasmussen, Chief financial officer
21
SEC EDGARThomas Altier, Chief financial officer
22
SEC EDGAREvan Roberts, Chief operating officer
23
SEC EDGARYvonne Hui, Principal Accounting Officer
24
SEC EDGARJanet Gunzburg, Principal Accounting Officer
25
SEC EDGARAmy Beth Vanduyn, SVP, Human Resources
26
SEC EDGARDaniel Nathan, Chief Technology Officer
27
SEC EDGARDavid Linetsky, SVP, Life Sciences
28
SEC EDGARMichael J. Davidoff, Officer
29
SEC EDGARLisa Egbuonu-Davis, Board member
30
SEC EDGARRamin Sayar, Board member
31
SEC EDGARLainie Goldstein, Board member
32
SEC EDGARCheryl Pegus, Board member
33
SEC EDGAREdward L. Cahill, Board member
34
SEC EDGARGillian Munson, Board member
35
SEC EDGARMichael Weintraub, Board member
36
SEC EDGARScott Perricelli, Board member
37
SEC EDGARAllison C. Hoffman, General counsel
38
SEC EDGARCharles Kallenbach, General counsel